JPRN-jRCT2080222382未知3 期
An Open-label Study to Evaluate the Efficacy and Safety of ABT-450/r/ABT-267 Co-administered With Ribavirin for 12 or 16 Weeks in Treatment-Naive and Treatment-Experienced Japanese Adults With Genotype 2 Chronic HCV Infection With and Without Compensated Cirrhosis (GIFT-II)
试验速览
- 阶段
- 3 期
- 发起方
- AbbVie GK
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Chronic HCV-infection prior to study enrollment
- •-Screening laboratory result indicating HCV genotype 2 infection
- •-Subject has plasma HCV RNA level greater than 10,000 IU/mL at Screening
- •-Voluntarily sign an informed consent
排除标准
- 未提供
研究者
相似试验
招募中
3 期
Phase 3 study to Evaluate the Efficacy and Safety of Avatrombopag in Japanese Adults with Chronic Immune ThrombocytopeniaChronic Immune ThrombocytopeniaJPRN-jRCT2031220005Shimizu Yasuko19
已完成
不适用
A clinical trial to assess the Efficacy and Safety of LPOTC001-11 versus Colgate Plax in dental plaques and gingivitisCTRI/2012/02/002460aila Pharmaceuticals Pvt Ltd40
进行中（未招募）
4 期
To Evaluate the Safety of an Ayurvedic Water Based Juice in Healthy VolunteersCTRI/2024/04/065700Sesa Care Private Limited
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Homozygous Familial HypercholesterolemiaMedDRA version: 20.0 Level: PT Classification code 10020603 Term: Hypercholesterolaemia System Organ Class: 10027433 - Metabolism and nutrition disordersHomozygous Familial HypercholesterolemiaEUCTR2017-002297-39-FRSanofi-Aventis Recherche & Développement50
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Homozygous Familial HypercholesterolemiaMedDRA version: 20.0Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersHomozygous Familial HypercholesterolemiaEUCTR2017-002297-39-SISanofi-Aventis Recherche & Développement50